indications for discharge/admission, 687
management and diagnostic studies, 686 –687 , 687 t
treatment, goals of, 685
triage considerations, 686
Carboxyhemoglobinemia, 123
Carcinomas, 910
Cardiac arrest
pathways, 45 f
signs and symptoms of lack of oxygen/glucose, 47 f
Cardiac Arrest Registry to Enhance Survival (CARES), 44 , 57 Cardiac emergencies
acquired heart disease, 611 –612
acute heart failure syndromes (AHFS), 610 –611 , 611 t, 612 f acute rheumatic fever, 614
arrhythmic emergencies, 600 –609
bacterial endocarditis, 614
cardiac tamponade, 614
cardiac trauma, 615 –616
cardiomyopathies, 612 –613
congenital heart disease (CHD), 588 –600
Kawasaki disease (KD), 615
myocardial ischemia (MI), 615
myocarditis, 613
patient evaluation with cardiac device, 616 –618
pericarditis, 613 –614
sudden cardiac death, 609 –610 , 611 f
therapy goals of, 588
Cardiac infections
brucella, 848
Chagas disease, 846
coronaviruses, 846
diphtheria, 847
lymphadenopathy, 847
measles, 847
mumps, 847 –848
Cardiac infectious emergencies
acquired heart disease, 611